Bamco Inc. NY Purchases 21,469 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Bamco Inc. NY increased its position in Stevanato Group S.p.A. (NYSE:STVN) by 1.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,685,181 shares of the company’s stock after purchasing an additional 21,469 shares during the period. Bamco Inc. NY’s holdings in Stevanato Group were worth $33,704,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Thrivent Financial for Lutherans purchased a new stake in shares of Stevanato Group in the second quarter worth approximately $30,477,000. Pembroke Management LTD lifted its stake in Stevanato Group by 143.7% during the 3rd quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock valued at $21,023,000 after acquiring an additional 619,747 shares in the last quarter. Tri Locum Partners LP purchased a new position in Stevanato Group during the 2nd quarter worth $10,370,000. Thornburg Investment Management Inc. grew its stake in shares of Stevanato Group by 279.1% in the 2nd quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock worth $13,690,000 after acquiring an additional 549,378 shares in the last quarter. Finally, Conestoga Capital Advisors LLC raised its holdings in shares of Stevanato Group by 7.3% in the second quarter. Conestoga Capital Advisors LLC now owns 7,275,823 shares of the company’s stock valued at $133,439,000 after purchasing an additional 496,930 shares during the last quarter.

Stevanato Group Trading Up 0.1 %

Shares of NYSE:STVN opened at €20.05 ($21.11) on Tuesday. Stevanato Group S.p.A. has a 1 year low of €16.56 ($17.43) and a 1 year high of €34.73 ($36.56). The business has a fifty day moving average price of €19.49 and a two-hundred day moving average price of €19.60. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million for the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. Stevanato Group’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.16 EPS. Sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.5 EPS for the current year.

Analysts Set New Price Targets

Separately, Citigroup reduced their price objective on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.